Actinium Pharmaceuticals Inc (ATNM)

[blukky]

FORM 8-K: ACTINIUM PHARMACEUTICALS FILES CURRENT REPORT [U.S. Fed News]

Fri Oct 19 23:20:27 2018 EDT

WASHINGTON, Oct. 20 -- Actinium Pharmaceuticals Inc., New York, files Form 8-K (current report) with Securities and Exchange Commission on Oct. 18.

State of Incorporation/State or other jurisdiction of incorporation: Delaware

Item 1.01 Entry into a Material Definitive Agreement.

On October 18, 2018, Actinium Pharmaceuticals, Inc. (the "Company") and Lincoln Park Capital Fund, LLC ("Lincoln Park") entered into a purchase agreement (the "Purchase Agreement") and a registration rights agreement (the "Registration Rights Agreement"), pursuant to which the Company has the right to sell to Lincoln Park shares of the Company's common stock having an aggregate value of up to $32,500,000, subject to certain limitations and conditions set forth in the Purchase Agreement (the "Offering").

More information can be viewed at: http://www.sec.gov/Archives/edgar/data/1388320/000121390018014103/f8k101918_actiniumpharma.htm For any query with respect to this article or any other content requirement, please contact Editor at [e-mail]

SID(HINDf7e795d6263628ed5f8)

ATNM

IC/hlth IC/hlth.phrm IS/biz.corpcomm IS/biz.filings IS/biz.form8k IS/biz.matevent IS/biz.spec IS/spec LC/us LR/am LR/nam